Chemist turned IP lawyer focusing on patent issues in the pharmaceutical, biotech and medical device industries; advocate for food allergy sufferers; beer lover
Boston, MA
Joined July 2011
- Tweets593
- Following183
- Followers119
- Likes440
Jonathan B. Roses retweeted
Thank you to all who attended Symposium 2025! Here is a sample of photos from the Fireside Chat with Director David Kappos and some of the sessions!
#bipla #bostonIP #intellectualproperty #bostonintellectualproperty #MAIP #DavidKappos
Jonathan B. Roses retweeted
On March 19, @Jonathan_Roses will lead a session at @ACI_Conferences's FDA Boot Camp in New York on patents and related protections. Learn more: hubs.ly/Q03b9l3F0
Jonathan B. Roses retweeted
John Strand was quoted in @Law360 discussing yesterday’s Dewberry Group v. Dewberry Engineers decision — a unanimous US Supreme Court ruling that could lead to more defendants in trademark litigation. #SCOTUS Read more: hubs.ly/Q038H8Hv0
Jonathan B. Roses retweeted
Our February Diversity & Inclusion Employee Spotlight features Nyasha Mombeshora, a Patent Paralegal in our Boston office. Why is diversity and inclusion in the workplace important to Nyasha? Nyasha answers this and more: wolfgreenfield.com/articles/…
Jonathan B. Roses retweeted
The intersection of AI and copyright remains a hot topic with much at stake. Dan Rudoy and Zach Westhoff examine fair use in copyright litigation and discuss the latest ruling in Thomson Reuters v. Ross in this article. Read more: hubs.ly/Q036NgYv0
Jonathan B. Roses retweeted
Congratulations to Aya Cieslak-Tochigi, counsel in our Trademark & Copyright Practice, for being selected as a member of the 2025 class of @LCLDNation Fellows. #LCLDNation Learn more: hubs.ly/Q036f5xj0
Jonathan B. Roses retweeted
Congrats to Jean Ge, associate in our Biotechnology Practice, and Charlotte Stewart-Sloan, associate in our Chemical & Materials Technologies Practice for being selected as members of the 2025 class of @LCLDNation Pathfinders. #LCLDNation Learn more: hubs.ly/Q036vyP60
Jonathan B. Roses retweeted
@Jonathan_Roses will co-host a session titled “Knowledge in the Open: Using Public Information to Strengthen Patent Cases” alongside Kelli Powell of Moderna on February 25 in Cambridge, MA at the Biotech Conference hosted by @PIUG and PhMTI. Learn more: hubs.ly/Q036FbFH0
Fun fact - Scott was painted head-to-toe in Eagles green and black while recording this podcast.
Scott McKeown (@PatentPostGrant) was featured on the @ipwatchdog Unleashed podcast, where he discusses patent reform efforts, whether the PTAB is working as intended, and causes for the PTAB invalidation rate with Gene Quinn. Listen here: hubs.ly/Q035dLjY0
Jonathan B. Roses retweeted
Wolf Greenfield has been ranked in Massachusetts and New York in the @WTR_Alerts 1000 – The World’s Leading Trademark Professionals 2025. In addition, attorneys received national individual recognition. Learn more: hubs.ly/Q034LVz40
Jonathan B. Roses retweeted
Scott McKeown (@PatentPostGrant) weighs in on when he expects a USPTO director to be appointed and what to expect between now and then in @ManagingIP: hubs.ly/Q033Nm2b0
Jonathan B. Roses retweeted
Jason Balich discusses what considerations companies should make when establishing a plan to ensure their trade secrets are protected in perpetuity in a column featured in @ChEnected's Chemical Engineering Progress (CEP) Magazine: hubs.ly/Q032vVFL0
Jonathan B. Roses retweeted
What do you need to know about this week’s Lynk Labs, Inc., v. Samsung Electronics Co., Ltd. Federal Circuit decision? Dan Brutti provides a summary and key takeaways: hubs.ly/Q032RBfP0
Jonathan B. Roses retweeted
2025 promises to be another busy year for intellectual property law. In this episode of IP Talk, Wolf Greenfield attorneys from a variety of practice areas review some of 2024's top issues and offer insights on what to expect in the months ahead. Listen: hubs.ly/Q031hCwW0
Jonathan B. Roses retweeted
Scott McKeown (@PatentPostGrant) discusses the most noteworthy developments of 2024 related to double patenting in @ipwatchdog's article about all the IP news that mattered this year. Read more: hubs.ly/Q030StYX0
Jonathan B. Roses retweeted
In our latest episode of IP Talk, Phil Hamzik, an associate in Wolf Greenfield’s Pharmaceutical Practice, discusses his work with pharma clients, his role as Chair of Wolf Greenfield's LGBTQ+ Affinity Group, and his activities outside the office. Listen: hubs.ly/Q030Pqm20
Jonathan B. Roses retweeted
John Strand discusses the biggest US trademark cases of 2024 in @WTR_Alerts: hubs.ly/Q030P4hc0
Jonathan B. Roses retweeted
The Court of Appeals for the Federal Circuit (CAFC) issued an important decision in Teva Branded Pharmaceutical Products R&D v. Amneal Pharmaceuticals on December 20th, 2024. Jonathan Roses discusses what you need to know in this IP alert: hubs.ly/Q030DM5V0
Happy New Year! 2024 set up an interesting IP landscape for 2025, and there are a number of patent cases (as well as executive and legislative actions) to watch in 2025. I enjoyed my conversation with @Law360 about Edwards v. Meril and the 271(e)(1) safe harbor.
What patent cases should you keep tabs on in 2025? @Jonathan_Roses weighs in on the Edwards v. Meril case in @Law360: hubs.ly/Q030_CgR0
Jonathan B. Roses retweeted
Scott McKeown (@PatentPostGrant) reflects on PTAB trends from 2024 and looks ahead to 2025 in @ManagingIP. How could the PTAB be affected by a new administration? Scott discusses this and more: hubs.ly/Q030nzgw0
